Related Experiment Videos
Inflammatory bowel disease therapy: an update
1Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA.
Comprehensive Therapy
|June 1, 1995
Summary
The range of treatments for inflammatory bowel disease (IBD) has expanded significantly. New therapies, including 5-ASA drugs and immunosuppressants, offer improved options alongside traditional treatments for better disease management.
Area of Science:
- Gastroenterology and immunology
Background:
- Inflammatory Bowel Disease (IBD) treatment has historically relied on sulfasalazine and corticosteroids.
- The therapeutic landscape for IBD has evolved significantly over the past decade.
Purpose of the Study:
- To review the expanded armamentarium for Inflammatory Bowel Disease (IBD) treatment.
- To highlight novel therapies and their potential impact on IBD management.
Main Methods:
- Review of current and emerging therapeutic agents for IBD.
- Discussion of the mechanisms of action for various IBD treatments.
Main Results:
- The availability of IBD treatments now includes 5-ASA drugs, antibiotics, immunosuppressive agents, and novel corticosteroids.
- Several new therapies are under investigation with promising early outcomes.
Conclusions:
- The expanded treatment options allow for personalized therapeutic strategies in IBD.
- Understanding treatment mechanisms will further elucidate IBD pathogenesis and guide future therapy selection.